መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › Pennsylvania › Philadelphia
በPhiladelphia፣ PA ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 13 ጥናቶች በPhiladelphia እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sidney Kimmel Cancer Center at Jefferson ( Site 0049), Philadelphia
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Pennsylvania Abramson Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · 7 ማይል ርቀት
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Pennsylvania (U Penn), Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
ተሳታዮችን በመፈለግ ላይ
- Thomas Jefferson University Hospital, Philadelphia
Role of the Immune Environment in Response to Therapy in Breast Cancer
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Abramson Cancer Center, Philadelphia
በሌሎች ከተሞች ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ጥናቶች
- Houston, TX42 ጥናቶች
- New York City, NY31 ጥናቶች
- Nashville, TN28 ጥናቶች
- Los Angeles, CA27 ጥናቶች
- Boston, MA26 ጥናቶች
- San Antonio, TX23 ጥናቶች
- St. Louis, MO21 ጥናቶች
- Arlington, VA20 ጥናቶች
- Atlanta, GA20 ጥናቶች
- Dallas, TX18 ጥናቶች
- Chicago, IL16 ጥናቶች
- Columbus, OH16 ጥናቶች
በPhiladelphia ውስጥ ያሉ ሌሎች ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)59 ጥናቶች
- የጡንቻ ካንሰር56 ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር51 ጥናቶች
- Metastatic Cancer46 ጥናቶች
- የፕሮስቴት ካንሰር44 ጥናቶች
- የኮሎሬክታል ካንሰር44 ጥናቶች
- የእንቁላል ካንሰር44 ጥናቶች
- የሳንባ ካንሰር36 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ34 ጥናቶች
- የልብ ድካም31 ጥናቶች
- የኤንዶሜትሪየም ካንሰር28 ጥናቶች
- ዲፕሬሽን26 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።